These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25693761)

  • 1. FDG PET/CT for bone and soft-tissue biopsy.
    Nanni C; Gasbarrini A; Cappelli A; Sandler I; Graziani T; Guidalotti P; Golfieri R; Boriani S; Fanti S
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1333-4. PubMed ID: 25693761
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of 18F-FDG PET-CT in the study of sacrococcygeal chordoma.
    Ochoa-Figueroa MA; Martínez-Gimeno E; Allende-Riera A; Cabello-García D; Muñoz-Iglesias J; Cárdenas-Negro C
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):359-61. PubMed ID: 23169392
    [No Abstract]   [Full Text] [Related]  

  • 6. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
    Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.
    Platzek I; Beuthien-Baumann B; Schramm G; Maus J; Laniado M; Kotzerke J; van den Hoff J; Schuler M
    Clin Imaging; 2017; 42():126-132. PubMed ID: 27951459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
    Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time FDG PET/CT-guided bone biopsy in a patient with two primary malignancies.
    Win AZ; Aparici CM
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1787-8. PubMed ID: 23828652
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
    Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
    Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
    Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
    Cerci JJ; Tabacchi E; Bogoni M
    PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.
    Treglia G; Ceriani L; Paone G; Rusca T; Bongiovanni M; Giovanella L
    Clin Nucl Med; 2014 Sep; 39(9):e402-4. PubMed ID: 24445271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
    Mammar H; Kerrou K; Nataf V; Pontvert D; Clemenceau S; Lot G; George B; Polivka M; Mokhtari K; Ferrand R; Feuvret L; Habrand JL; Pouysségur J; Mazure N; Talbot JN
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):681-7. PubMed ID: 22391104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT differentiating two malignant tumors in the same patient.
    Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
    Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced multiple myeloma with negative bone marrow biopsy and positive soft tissue lesions in the (18)F-FDG PET/CT scan.
    Ceneli O; Haznedar R
    Hell J Nucl Med; 2008; 11(1):56-7. PubMed ID: 18392234
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
    Yanagawa T; Shinozaki T; Iizuka Y; Takagishi K; Watanabe H
    J Bone Joint Surg Br; 2010 Mar; 92(3):419-23. PubMed ID: 20190315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary imaging in sarcoma.
    Landa J; Schwartz LH
    Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
    Kim JY; Park J; Choi YY; Lee S; Paik SS
    Clin Nucl Med; 2015 Feb; 40(2):172-4. PubMed ID: 25140556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.